• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撒哈拉以南非洲的宫颈癌:一种可预防的非传染性疾病。

Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.

机构信息

a Laboratoire de virologie, hôpital Européen Georges Pompidou , Assistance Publique-Hôpitaux de Paris , France.

b Department of Immunology, INSERM U970 , Université Paris Descartes, Sorbonne Paris-Cité , Paris , France.

出版信息

Expert Rev Anti Infect Ther. 2017 Jun;15(6):613-627. doi: 10.1080/14787210.2017.1322902. Epub 2017 May 5.

DOI:10.1080/14787210.2017.1322902
PMID:28440679
Abstract

Infections caused by high-risk human papillomavirus (HPV) are responsible for 7.7% of cancers in developing countries, mainly cervical cancer. This disease is steadily increasing in sub-Saharan Africa, with more than 75,000 new cases and 50,000 deaths yearly, further increased by HIV infection. Areas covered: The current status of cervical cancer associated with HPV in sub-Saharan Africa has been systematically revised. The main issues discussed here are related to the public health burden of cervical cancer in sub-Saharan Africa and predictions for the coming decades, including molecular epidemiology and determinants of HPV infection in Africa, and promising prevention measures currently being evaluated in Africa. Expert commentary: By the year 2030, cervical cancer will kill more than 443,000 women yearly worldwide, most of them in sub-Saharan Africa. The increase in the incidence of cervical cancer in Africa could counteract the progress made by African women in reducing maternal mortality and longevity. Nevertheless, cervical cancer is a potentially preventable noncommunicable disease, and intervention strategies to eliminate cervical cancer as a public health concern should be urgently implemented.

摘要

在发展中国家,由高危型人乳头瘤病毒(HPV)引起的感染占癌症的 7.7%,主要是宫颈癌。这种疾病在撒哈拉以南非洲地区呈稳步上升趋势,每年新增病例超过 7.5 万例,死亡病例超过 5 万例,且因 HIV 感染而进一步增加。

涵盖领域

系统回顾了与撒哈拉以南非洲地区 HPV 相关的宫颈癌的现状。本文主要讨论了与撒哈拉以南非洲地区宫颈癌的公共卫生负担相关的问题,并对未来几十年进行了预测,包括非洲 HPV 感染的分子流行病学和决定因素,以及目前正在非洲评估的有前途的预防措施。

专家评论

到 2030 年,全世界每年将有超过 44.3 万名妇女死于宫颈癌,其中大多数在撒哈拉以南非洲地区。非洲宫颈癌发病率的上升可能会抵消非洲妇女在降低孕产妇死亡率和延长寿命方面取得的进展。然而,宫颈癌是一种潜在可预防的非传染性疾病,消除宫颈癌这一公共卫生关注点的干预策略应紧急实施。

相似文献

1
Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.撒哈拉以南非洲的宫颈癌:一种可预防的非传染性疾病。
Expert Rev Anti Infect Ther. 2017 Jun;15(6):613-627. doi: 10.1080/14787210.2017.1322902. Epub 2017 May 5.
2
Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.撒哈拉以南非洲地区的宫颈癌:一种与致癌性人乳头瘤病毒相关的新出现且可预防的疾病。
Med Sante Trop. 2017 Feb 1;27(1):16-22. doi: 10.1684/mst.2017.0648.
3
Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).预防人免疫缺陷病毒(HIV)感染者的人乳头瘤病毒(HPV)相关肿瘤。
Expert Rev Anti Infect Ther. 2017 Nov;15(11):987-999. doi: 10.1080/14787210.2017.1392854. Epub 2017 Oct 20.
4
Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.基于模型的撒哈拉以南非洲地区宫颈癌预防的影响和成本效益。
Vaccine. 2013 Dec 29;31 Suppl 5:F60-72. doi: 10.1016/j.vaccine.2012.07.093.
5
Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?人乳头瘤病毒在撒哈拉以南非洲浸润性宫颈癌中的分布:HIV 能解释差异吗?
Trop Med Int Health. 2012 Dec;17(12):1432-40. doi: 10.1111/tmi.12004. Epub 2012 Oct 29.
6
Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.撒哈拉以南非洲地区人乳头瘤病毒疫苗接种和宫颈癌筛查的基础设施要求。
Vaccine. 2013 Dec 29;31 Suppl 5:F47-52. doi: 10.1016/j.vaccine.2012.06.066.
7
Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.撒哈拉以南非洲的宫颈癌和人乳头瘤病毒预防试验和项目。
Vaccine. 2013 Dec 29;31 Suppl 5:F53-9. doi: 10.1016/j.vaccine.2012.06.070.
8
The burden of human papillomavirus infections and related diseases in sub-saharan Africa.撒哈拉以南非洲地区人乳头瘤病毒感染及相关疾病的负担。
Vaccine. 2013 Dec 29;31 Suppl 5(0 5):F32-46. doi: 10.1016/j.vaccine.2012.07.092.
9
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.人乳头瘤病毒在俄罗斯联邦、前苏联西方国家、高加索地区和中亚的流行情况和型别分布、宫颈癌筛查实践以及疫苗接种实施现状。
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.
10
Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.撒哈拉以南非洲地区人乳头瘤病毒与宫颈癌的流行病学及预防:全面综述
Trop Med Int Health. 2009 Oct;14(10):1287-302. doi: 10.1111/j.1365-3156.2009.02372.x.

引用本文的文献

1
The High Prevalence of Oncogenic HPV Genotypes Targeted by the Nonavalent HPV Vaccine in HIV-Infected Women Urgently Reinforces the Need for Prophylactic Vaccination in Key Female Populations Living in Gabon.加蓬感染艾滋病毒女性中九价人乳头瘤病毒疫苗所针对的致癌性人乳头瘤病毒基因型的高流行率,迫切凸显了在该国关键女性人群中进行预防性疫苗接种的必要性。
Diseases. 2025 Aug 14;13(8):260. doi: 10.3390/diseases13080260.
2
Higher plasma AFB1 concentration is associated with increased risk of HPV 16 and HPV 18 detection and persistence among Ugandan women.较高的血浆黄曲霉毒素B1浓度与乌干达女性中检测到人乳头瘤病毒16型和18型以及病毒持续存在的风险增加有关。
Environ Health. 2025 Jul 7;24(1):45. doi: 10.1186/s12940-025-01197-0.
3
Human Papillomavirus and Other Relevant Issues in Cervical Cancer Pathogenesis.
人乳头瘤病毒与宫颈癌发病机制中的其他相关问题。
Int J Mol Sci. 2025 Jun 10;26(12):5549. doi: 10.3390/ijms26125549.
4
Syndemic Synergy of HPV, HIV, and HSV-2 for Oncogenic HPV Replication in Female Sex Workers.人乳头瘤病毒、艾滋病毒和单纯疱疹病毒2型在女性性工作者中对致癌性人乳头瘤病毒复制的综合征协同作用
Trop Med Infect Dis. 2025 Jun 7;10(6):157. doi: 10.3390/tropicalmed10060157.
5
Successful Retrieval of Human Papillomavirus DNA in Veil-Based Collected Female Genital Secretions After Long-Term Storage in Universal Transport Medium.在通用运输培养基中长期保存后,成功从基于面纱收集的女性生殖分泌物中提取人乳头瘤病毒DNA。
Diagnostics (Basel). 2025 Apr 24;15(9):1079. doi: 10.3390/diagnostics15091079.
6
Factors associated with cervical cancer screening among women of reproductive age in Moshi municipality, Kilimanjaro, Tanzania: a cross-sectional study.坦桑尼亚乞力马扎罗莫希市育龄妇女宫颈癌筛查相关因素:一项横断面研究
BMJ Open. 2025 Jan 23;15(1):e085223. doi: 10.1136/bmjopen-2024-085223.
7
Understanding cervical cancer prevention in Africa: a qualitative systematic review of the role of men.了解非洲的宫颈癌预防:对男性作用的定性系统评价
BMJ Open. 2024 Dec 23;14(12):e080416. doi: 10.1136/bmjopen-2023-080416.
8
Uptake of cervical cancer screening among sex workers living with HIV in Nairobi, Kenya: a cross-sectional study.肯尼亚内罗毕感染艾滋病毒的性工作者宫颈癌筛查情况:一项横断面研究。
Ther Adv Infect Dis. 2024 Sep 30;11:20499361241284238. doi: 10.1177/20499361241284238. eCollection 2024 Jan-Dec.
9
Cervical cancer screening utilization and associated factors among women living with HIV in Ethiopia, 2024: systematic review and meta-analysis.埃塞俄比亚 HIV 感染者中宫颈癌筛查的利用及其影响因素:系统评价和荟萃分析。
BMC Womens Health. 2024 Sep 19;24(1):521. doi: 10.1186/s12905-024-03362-y.
10
Human Papillomavirus Genotypes Distribution in High-Grade Cervical Lesions and Invasive Cervical Carcinoma in Women Living in Mauritania: Implications for Cervical Cancer Prevention and HPV Prophylactic Vaccination.毛里塔尼亚女性高级别宫颈病变和浸润性宫颈癌中人类乳头瘤病毒基因型分布:对宫颈癌预防和人乳头瘤病毒预防性疫苗接种的意义
Diagnostics (Basel). 2024 Sep 8;14(17):1986. doi: 10.3390/diagnostics14171986.